|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Amortization of intangible assets | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Marketing and selling | |||||
| Research and development | |||||
| General and administrative | |||||
| Amortization of intangible assets and acquisition-related costs | |||||
| Impairment of intangible assets | |||||
| Change in fair value of contingent consideration for business acquisition | |||||
| Restructuring charges, net | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest income | |||||
| Other income (expense), net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares used to compute net income per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...